Episurf Medical (Nasdaq: EPIS B) today announces that the abstract “Episealer, a mini metal implant for chondral injuries in the knee. A prospective single surgeon case series”, has been accepted for a podium presentation at the combined Australian and New Zealand Knee Societies meeting, which will take place in Queenstown, New Zealand, on October 27 – 29, 2022. The presentation will be held by Prof. Karl Eriksson from Stockholm South Hospital and The Karolinska Institute, Stockholm, Sweden.

The abstract reports on the clinical outcome for patients having undergone treatment with Episurf Medical’s personalised knee implant Episealer® for treatment of isolated chondral and osteochondral defects in the knee, at Stockholm South Hospital.

“We are very interested in following the results from this prospective study performed at Stockholm South Hospital, with follow up of Episealer® patients. We are about to introduce the Episealer® product family in Australia and New Zealand, and we are happy to see the interest shown from the Australian and New Zealand Knee Societies”, says Pål Ryfors, CEO Episurf Medical.